November 13, 2007
Press Release no.1
Market-wide Position
Limit in OMAXE, POWERGRID & ADLABSFILM
The derivative contracts in the underlying
OMAXE, POWERGRID & ADLABSFILM have crossed 95% of the market-wide position
limit on November 13, 2007. It is hereby informed that all clients/ members
shall trade in derivative contracts of
OMAXE, POWERGRID & ADLABSFILM by offsetting their existing positions
till the open interest comes down to 80% of the market wide position limit.
Press Release no.2
News
about Matrix Laboratories
Limited
The media had reports that Mylan may come out with a delisting offer for
Matrix and are looking at buying the residual stake.
The Exchange, in order to verify the accuracy or
otherwise of the information reported in the media and to inform the market
place so that the interest of the investors is safeguarded, had written to the
officials of the company.
Matrix Laboratories Limited has vide its letter
inter-alia stated,"As on date Mylan Laboratories Inc.,
Press Release no.3
NSE
completes its 1937th & 1938th Normal Settlements
The Exchange have successfully
completed its 1937th & 1938th Normal Settlement
(Rolling T+2 following SEBI directive) since inception i.e., Settlement Numbers
N – 2007214 & 2007215 on November 13, 2007. The settlement statistics is as
follows:
Particulars
|
Values
|
Values
|
|
N – 2007214
|
N- 2007215
|
Total traded quantity (lakhs) |
5872.93 |
1766.52 |
Total traded value (Rs. In Crores) |
16761.87 |
3171.18 |
Total value of
the settlement (Securities) (Rs. In Crores) |
4681.16 |
886.20 |
Total value of the settlement (Funds) (Rs. In Crores) |
1555.02 |
506.99 |
Shortages for the settlement
|
0.36% |
0.50% |
% of Delivery ( No. of
shares deliverable / No. of shares traded ) |
22.43% |
25.14% |
Retail Debt Market have completed its 1211th & 1212th
settlements details of which are as follows:
Settlement No. |
Traded Value |
Settlement Value |
|
|
|
Securities |
Funds |
D- 2007214 |
NIL |
NIL |
NIL |
D- 2007215 |
NIL |
NIL |
NIL |